Fred Alger Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.7M Sell
304,896
-47,213
-13% -$10.6M 0.31% 45
2025
Q4
$75.1M Buy
352,109
+181,408
+106% +$37.5M 0.29% 47
2025
Q3
$33.9M Buy
170,701
+166,906
+4,398% +$31.1M 0.13% 85
2025
Q2
$655K Sell
3,795
-61,011
-94% -$9.94M ﹤0.01% 377
2025
Q1
$10.1M Sell
64,806
-47,048
-42% -$6.72M 0.06% 171
2024
Q4
$15.4M Sell
111,854
-146,356
-57% -$19.2M 0.07% 154
2024
Q3
$38.6M Sell
258,210
-48,863
-16% -$6.6M 0.19% 89
2024
Q2
$41.9M Buy
307,073
+120,952
+65% +$16.5M 0.2% 84
2024
Q1
$28.1M Sell
186,121
-7,381
-4% -$1.05M 0.14% 120
2023
Q4
$24.4M Sell
193,502
-76,503
-28% -$7.63M 0.13% 131
2023
Q3
$25.3M Sell
270,005
-81,006
-23% -$7.58M 0.15% 132
2023
Q2
$31.3M Buy
+351,011
New +$30.5M 0.16% 134
2023
Q1
Sell
-14,556
Closed -$1.78M 524
2022
Q4
$1.78M Buy
+14,556
New +$1.69M 0.01% 352
2020
Q3
Sell
-5,000
Closed -$740K 466
2020
Q2
$740K Hold
5,000
﹤0.01% 372
2020
Q1
$563K Sell
5,000
-500
-9% -$65K ﹤0.01% 352
2019
Q4
$765K Sell
5,500
-1,500
-21% -$167K ﹤0.01% 362
2019
Q3
$674K Hold
7,000
﹤0.01% 360
2019
Q2
$806K Sell
7,000
-1,500
-18% -$179K ﹤0.01% 353
2019
Q1
$1M Buy
+8,500
New +$744K ﹤0.01% 333

Other funds holding ASND